Prosecution Insights
Last updated: November 20, 2026
Application No. 18/938,150

SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA

Final Rejection §101§112
Filed
Nov 05, 2024
Priority
Dec 17, 2007 — provisional 61/014,398 +5 more
Examiner
BLOCH, MICHAEL RYAN
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
DexCom Inc.
OA Round
2 (Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
2y 2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
318 granted / 632 resolved
-19.7% vs TC avg
Strong +55% interview lift
Without
With
+55.1%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
49 currently pending
Career history
693
Total Applications
across all art units

Statute-Specific Performance

§101
22.3%
-17.7% vs TC avg
§103
26.2%
-13.8% vs TC avg
§102
12.2%
-27.8% vs TC avg
§112
33.2%
-6.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 632 resolved cases

Office Action

§101 §112
DETAILED ACTION Acknowledgements The present application is being examined under the pre-AIA first to invent provisions. Claims 21-39, 41 are pending. This action is Final. Internet communication is authorized by the filing of 11/5/2024. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 41 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 41, the claim further limits the method of claim 21 with the limitations “adjusting display of the calibrated sensor data based at least in part on the measure of the ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts the analyte concentration in the host” which renders the claim indefinite. The issue here is that there is nothing claimed for “displaying” or “display” in claim 21 to allow for any kind of “adjusting”. This makes the metes and bounds of the claim unclear, which renders the claim indefinite. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 21, 27-30, 36-39, 41 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception without significantly more. The claim(s) recite(s): Claim 21 converting at least the first data to calibrated sensor data using a conversion function based at least on one or more parameters (mathematical concepts/mental processes including pen and paper) determining, based at least on the first data and the second data, a measure of an ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts an analyte concentration in a host, wherein the measure is different from the one or more parameters (mathematical concepts/mental processes including pen and paper); and calibrating the transcutaneous analyte sensor based at least on the measure of the ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts the analyte concentration in the host (mathematical concepts/mental processes including pen and paper) Claim 30 converting at least the first data to calibrated sensor data using a conversion function based at least on one or more parameters (mathematical concepts/mental processes including pen and paper) determining, based at least on the first data and the second data, a measure of an ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts an analyte concentration in a host, wherein the measure is different from the one or more parameters (mathematical concepts/mental processes including pen and paper) calibrating the transcutaneous analyte sensor based at least on the measure of the ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts the analyte concentration in the host (mathematical concepts/mental processes including pen and paper) Claim 39 converting at least the first data to calibrated sensor data using a conversion function based at least on one or more parameters (mathematical concepts/mental processes including pen and paper); determining, based at least on the first data and the second data, a measure of an ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts an analyte concentration in a host, wherein the measure is different from the one or more parameters (mathematical concepts/mental processes including pen and paper); and calibrating the transcutaneous analyte sensor based at least on the measure of the ability of the transcutaneous analyte sensor to produce the calibrated sensor data that accurately predicts the analyte concentration in the host (mathematical concepts/mental processes including pen and paper) These claim limitations fall within the identified groupings of abstract ideas: Mathematical Concepts: mathematical relationships mathematical formulas or equations mathematical calculations Mental Processes concepts performed in the human mind (including an observation, evaluation, judgment, opinion) This judicial exception is not integrated into a practical application because: Under the step 2A, analysis is conducted on the additional features of the claim. Under this analysis, the additional features beyond the judicial exception are: Claim 21 receiving sensor data from a transcutaneous analyte sensor comprising a first electrode configured to generate an analyte signal and a second electrode configured to generate a non- enzyme background signal, wherein the sensor data includes first data associated with the analyte signal and second data associated with the non-enzyme background signal (insignificant extra solution data gathering) Claim 30 one or more processors (generic computer structures used as tools for implementation) a memory storing instructions that are executable by the one or more processors to cause the system to perform operations including: (generic computer structures used as tools for implementation) receiving sensor data from a transcutaneous analyte sensor comprising a first electrode configured to generate an analyte signal and a second electrode configured to generate a non-enzyme background signal, wherein the sensor data includes first data associated with the analyte signal and second data associated with the non-enzyme background signal (insignificant extra solution data gathering) Claim 39 a non-transitory computer storage component storing instructions that are executable by one or more processors to perform operations comprising: (generic computer structures used as tools for implementation) receiving sensor data from a transcutaneous analyte sensor comprising a first electrode configured to generate an analyte signal and a second electrode configured to generate a non- enzyme background signal, wherein the sensor data includes first data associated with the analyte signal and second data associated with the non-enzyme background signal (insignificant extra solution data gathering) These features in the claim do not integrate the exception into a practical application of the exception as the additional elements in the claim do not apply, rely on, or use the judicial exception in a manner that imposes a meaningful limit on the judicial exception, such that the claim is no more than a drafting effort designed to monopolize the exception. Limitation concepts that are indicative of integration into a practical application: Improvements to the functioning of a computer, or to any other technology or technical field - see MPEP 2106.05(a) Applying or using a judicial exception to effect a particular treatment or prophylaxis for a disease or medical condition – see Vanda Memo Applying the judicial exception with, or by use of, a particular machine - see MPEP 2106.05(b) Effecting a transformation or reduction of a particular article to a different state or thing - see MPEP 2106.05(c) Applying or using the judicial exception in some other meaningful way beyond generally linking the use of the judicial exception to a particular technological environment, such that the claim as a whole is more than a drafting effort designed to monopolize the exception - see MPEP 2106.05(e) and Vanda Memo Limitation concepts that are not indicative of integration into a practical application: Adding the words “apply it” (or an equivalent) with the judicial exception, or mere instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea - see MPEP 2106.05(f) Adding insignificant extra-solution activity to the judicial exception - see MPEP 2106.05(g) Generally linking the use of the judicial exception to a particular technological environment or field of use – see MPEP 2106.05(h) Under Step 2B, the claim limitations are evaluated for an inventive concept. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because, when considered separately and in combination, they do not add significantly more to the exception. Analyzing the additional claim limitations individually, the additional limitation that is not directed to the abstract idea are the same as those identified above in 2A. Such limitations related to the sensors are recognized by the courts as routine data gathering in order to input data to the mathematical algorithm/mental process, and thus, do not add a meaningful limitation to the method as it would be routinely used by those of ordinary skill in the art in order to apply the mathematical algorithm. In addition, these sensor structures are known from US 6275717, US 6931327, US 2005/0192557, and US 2005/0027463, and in general producing the expected related data signals. The method does not contain any computing structure, such that the steps can all be analog/mental processing of the equation from the data gathered which further supports that the claims are directed to a judicial exception without significantly more. The computer structures cited above are claimed as performing generic computer functions routinely used in computer applications. Generic computer components recited as performing generic computer functions that are well-understood, routine and conventional activities amount to no more than implementing the abstract idea with a computerized system. The dependent claims are directed to further aspects of the judicial exception and/or details related to the data gathering, and insignificant post solution activities of adjusting display. Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. Therefore, analyzing the claims as an ordered combination under the Mayo/Alice analysis the features claimed are directed to patent ineligible limitations. The additional limitations recited in the dependent claims 22, 31, 40 are sufficient. Response to Arguments The examiner acknowledges applicant’s submission of amendments to the claims filed 10/14/2026. Applicant’s arguments regarding the rejections of the claims under 35 U.S.C. 101 have been fully considered but are not persuasive. Applicant argues that the claims are a practical application improving a dual electrode sensor by producing more accurate calibrated sensor data. This is not found persuasive as the improvement is to the exception itself. The dual electrode system (working/reference) is a well-known combination in the analyte sensing arts. The citation to the passage in 325 describes the advantage of using a dual electrode system not an improvement to the dual electrode system, itself and the examiner is unpersuaded by this argument and position taken by applicant. [0325] “The non-analyte (e.g., non-glucose) signal produced by compounds other than the analyte (e.g., glucose) obscures the signal related to the analyte, contributes to sensor inaccuracy, and is considered background noise. Background noise includes both constant and non-constant components and must be removed to accurately calculate the analyte concentration. While not wishing to be bound by theory, it is believed that preferred dual electrode sensors are designed such that the first and second electrodes are influenced by substantially the same external/environmental factors, which enables substantially equivalent measurement of both the constant and non-constant species/noise. This advantageously allows the substantial elimination of noise on the sensor signal (using electronics described elsewhere herein) to substantially reduce or eliminate signal effects due to noise, including non-constant noise (e.g., unpredictable biological, biochemical species, medicaments, pH fluctuations, O2 fluctuations, or the like) known to effect the accuracy of conventional continuous sensor signals. Preferably, the sensor includes electronics operably connected to the first and second working electrodes. The electronics are configured to provide the first and second signals that are used to generate glucose concentration data substantially without signal contribution due to non-glucose-related noise. Preferably, the electronics include at least a potentiostat that provides a bias to the electrodes. In some embodiments, sensor electronics are configured to measure the current (or voltage) to provide the first and second signals. The first and second signals are used to determine the glucose concentration substantially without signal contribution due to non-glucose-related noise such as by but not limited to subtraction of the second signal from the first signal or alternative data analysis techniques. In some embodiments, the sensor electronics include a transmitter that transmits the first and second signals to a receiver, where additional data analysis and/or calibration of glucose concentration can be processed. U.S. Patent Publication No. US-2005-0027463-A1, US-2005-0203360-A1 and U.S. Patent Publication No. US-2006-0036142-A1 describes systems and methods for processing sensor analyte data and is incorporated herein by reference in their entirety.” Based on the passage cited, the use of the dual system itself is the improvement, but the further processing of data for predicting accuracy is not stated as the improvement in the art and is related to the expected data signals gathered and in novel processing of the data as set forth, but novelty does not equate to patentability without significantly more or a practical application of an exception. The claims do not meet the threshold of more likely patent eligible than not in the current form of the independent claims. The rejections are respectfully maintained as updated to account for the amendments to the claims. Allowable Subject Matter Claims 22-26, 31-35 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The most pertinent art of record teaches similar concepts of calibrating sensors, and determining accuracy including US 2005/0004439, US 2008/0161664, US 6,919,566, US 2006/0258929, US 2005/0027180, but for the claimed priority date, the art of record fails to teach, suggest, or reasonably make obvious the features of: wherein the sensor data includes first data associated with the analyte signal and second data associated with the non-enzyme background signal; converting at least the first data to analyte data using a conversion function based at least on one or more parameters; determining, based at least on the first data and the second data, a measure of an ability of the transcutaneous analyte sensor to produce calibrated sensor data that accurately predicts an analyte concentration in a host, wherein the measure is different from the one or more parameters; and calibrating the transcutaneous analyte sensor based at least on the measure of the ability of the transcutaneous analyte sensor to produce calibrated sensor data that accurately predicts the analyte concentration in the host, in view of the remaining elements of the claims, and when considered as a whole. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL R BLOCH whose telephone number is (571)270-3252. The examiner can normally be reached M-F 11-8 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert (Tse) Chen can be reached at (571)272-3672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL R BLOCH/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Nov 05, 2024
Application Filed
Jul 15, 2025
Response after Non-Final Action
Jul 14, 2026
Non-Final Rejection mailed — §101, §112
Oct 14, 2026
Response Filed
Nov 05, 2026
Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788270
LUNG HEALTH SENSING THROUGH VOICE ANALYSIS
5y 2m to grant Granted Nov 10, 2026
Patent 12778511
PRESSURE SENSING IMPLANT
3y 5m to grant Granted Nov 03, 2026
Patent 12773135
PROGRAMMABLE EPIDERMAL MICROFLUIDIC VALVING SYSTEM FOR WEARABLE BIOFLUID MANAGEMENT AND CONTEXTUAL BIOMARKER ANALYSIS
5y 2m to grant Granted Oct 27, 2026
Patent 12765830
Craniode
3y 5m to grant Granted Oct 20, 2026
Patent 12758121
BREATH SAMPLER
3y 10m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+55.1%)
4y 2m (~2y 2m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 632 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month